Trofinetide

N/A

Report date: 2024/11/06 10:20:14
NME

Base Information

Drug NameTrofinetide
Drug Alias Name曲非奈肽Trofinetidum卓非奈肽TrofinetidaGlycyl-L-2-methylprolyl-L-glutamic acid +[9] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlial cells modulatorsCytokines inhibitorsNeuropeptide receptor modulators
TargetsNeuropeptide receptorCytokines
Therapy Area/IndicationsRett SyndromeFragile X SyndromeBrain Concussion +[5] 
Global Approved IndicationsRett Syndrome
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2023/03/10
Country/TerritoryCanadaUnited StatesAustralia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesWalter Reed Army InstitutePolynovoNeuren Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAcadia Pharmaceuticals Inc
Inactive CompaniesNeuren Pharmaceuticals Ltd
Active IndicationsRett Syndrome
Inactive IndicationsFragile X SyndromeBrain ConcussionBrain Injuries, Traumatic +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG